The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled. Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Insurance coverage litigation for Formosa Plastics Corporation for explosion and fire loss
The firm served as lead counsel for Formosa Plastics Corporation in litigation regarding coverage for property damage and other losses suffered at more
Centennial Healthcare going-private transaction
Represented the Special Committee of the Board of Centennial Healthcare, an operator of more than 100 nursing home facilities, in its consideration more
Counsel to the State of South Carolina Regarding Interstate Port Development Treaty
Represented the State of South Carolina in connection with the execution of a historic bi-state agreement with the State of Georgia providing for the more
Halted auction of GRAMMY Award for The National Academy of the Recording Arts & Sciences
Represented The National Academy of the Recording Arts & Sciences, the organization which administers the prestigious GRAMMY award ceremony, in more